Integrating long-acting injectable cabotegravir for HIV prevention into the Brazilian public health system (ImPrEP CAB Brasil): a hybrid type-2 implementation-effectiveness cohort study
AIDS 2026: EVIDENCE AND LESSONS LEARNED ON LONG-ACTING PREP IN LATIN AMERICA– THE IMPREP PROJECT (SATELLITE SYMPOSIUM)
AIDS 2026: IMPACT OF DOXY-PEP ON SEXUALLY TRANSMITTED INFECTIONS DIAGNOSES AND ANTIBIOTIC USE AMONG MEN WHO HAVE SEX WITH MEN AND TRANSGENDER WOMEN ON PREP IN BRAZIL: A MODELLING STUDY (ORAL PRESENTATION)
AIDS 2026: CHALLENGES IN EARLY HIV DETECTION DURING CAB‑LA PREP: CHARACTERIZATION OF INCONCLUSIVE SEROLOGICAL RESULTS IN IMPREP CAB BRASIL (ORAL PRESENTATION)
